Receptor.AI is a TechBio drug discovery company that combines a multi-platform AI ecosystem with a modality-agnostic decision engine to define the right therapeutic strategy and design the right molecule to address complex target biology.



Our ecosystem integrates small molecules, peptides, and induced-proximity therapeutics, enabling objective comparison and selection of drug discovery approaches. This allows us to design molecules that align with strategic program direction and increase the probability of clinical success.



We partner with pharma and biotech organizations to advance high-confidence programs toward the clinic, with capabilities validated across 40+ discovery programs and guided by experts behind FDA-approved and clinical-stage medicines.